These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31418063)

  • 41. Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal.
    Dromigny JA; Nabeth P; Perrier Gros Claude JD
    Int J Antimicrob Agents; 2002 Nov; 20(5):339-47. PubMed ID: 12431869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
    BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility of uropathogens isolated from Cambodian children.
    Moore CE; Sona S; Poda S; Putchhat H; Kumar V; Sopheary S; Stoesser N; Bousfield R; Day N; Parry CM
    Paediatr Int Child Health; 2016 May; 36(2):113-7. PubMed ID: 25704569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The best rules for antimicrobial stewardship in urogenital tract infections.
    Kulchavenya E
    Curr Opin Urol; 2020 Nov; 30(6):838-844. PubMed ID: 32881727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
    Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria.
    Nieminen O; Korppi M; Helminen M
    Acta Paediatr; 2017 Feb; 106(2):327-333. PubMed ID: 27891664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study.
    Amin O; Prestel C; Gonzalez MD; Lyon T; Shane A; Jaggi P; Tippett A; Yildirim I
    Pediatr Infect Dis J; 2020 Mar; 39(3):211-216. PubMed ID: 32032306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial profile, antibiotic susceptibility pattern and associated risk factors of urinary tract infection among clinically suspected children attending at Felege-Hiwot comprehensive and specialized hospital, Northwest Ethiopia. A prospective study.
    Fenta A; Dagnew M; Eshetie S; Belachew T
    BMC Infect Dis; 2020 Sep; 20(1):673. PubMed ID: 32938424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidrug resistance in pediatric urinary tract infections.
    Gaspari RJ; Dickson E; Karlowsky J; Doern G
    Microb Drug Resist; 2006; 12(2):126-9. PubMed ID: 16922629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended-spectrum beta-lactamase
    Vachvanichsanong P; McNeil EB; Dissaneewate P
    Epidemiol Infect; 2020 Dec; 149():e12. PubMed ID: 33327984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
    Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
    BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children.
    Paschke AA; Zaoutis T; Conway PH; Xie D; Keren R
    Pediatrics; 2010 Apr; 125(4):664-72. PubMed ID: 20194282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
    Gomila A; Shaw E; Carratalà J; Leibovici L; Tebé C; Wiegand I; Vallejo-Torres L; Vigo JM; Morris S; Stoddart M; Grier S; Vank C; Cuperus N; Van den Heuvel L; Eliakim-Raz N; Vuong C; MacGowan A; Addy I; Pujol M;
    Antimicrob Resist Infect Control; 2018; 7():111. PubMed ID: 30220999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
    Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
    Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
    Abe Y; Inan-Erdogan I; Fukuchi K; Wakabayashi H; Ogawa Y; Hibino S; Sakurai S; Matsuhashi K; Watanabe Y; Hashimoto K; Ugajin K; Itabashi K
    J Infect Chemother; 2017 Aug; 23(8):517-522. PubMed ID: 28528936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.